Literature DB >> 10340524

Dopamine antagonists in the orbital prefrontal cortex reduce prepulse inhibition of the acoustic startle reflex in the rat.

K Zavitsanou1, J Cranney, R Richardson.   

Abstract

Schizophrenia is characterized by, among other things, (a) information processing deficits that have been indexed by a number of measures, including deficits in prepulse inhibition (PPI) of the acoustic startle reflex; and (b) pathophysiology of the frontal lobe. Recent studies have implicated the prefrontal cortex (PFC) in the modulation of PPI in rats. These studies suggest that dopamine (DA) ablation of the PFC (using 6-OHDA) leads to disruption of PPI. To better understand the role of DA type 1 (D1) and type 2 (D2) receptors in the modulation of PPI, we investigated the effects of two pharmacologically distinct DA antagonists on the modulation of PPI. Microinjection of SCH23390 (a D1 antagonist) into the orbital PFC markedly decreased PPI (at 0.1, 0.5, and 1.5 microg), whereas raclopride (a D2 antagonist) decreased PPI at some doses (0.1 and 0.5 mg/ml) but not at others (5.0 microg). We conclude that both D1 and D2 receptors mediate the cortical modulation of PPI.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10340524     DOI: 10.1016/s0091-3057(98)00234-2

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  21 in total

1.  Effect of lateralized gaps in noise on the cutaneous blink reflex in humans.

Authors:  G Hammond
Journal:  Cogn Affect Behav Neurosci       Date:  2001-09       Impact factor: 3.282

2.  Reduced startle gating after D1 blockade: effects of concurrent D2 blockade.

Authors:  Neal R Swerdlow; Jody M Shoemaker; Michele J Bongiovanni; Alaina C Neary; Laura S Tochen; Richard L Saint Marie
Journal:  Pharmacol Biochem Behav       Date:  2005-09-26       Impact factor: 3.533

3.  Neonatal neurosteroid administration results in development-specific alterations in prepulse inhibition and locomotor activity: neurosteroids alter prepulse inhibition and locomotor activity.

Authors:  Samantha S Gizerian; Sheryl S Moy; Jeffrey A Lieberman; A Chistina Grobin
Journal:  Psychopharmacology (Berl)       Date:  2006-04-04       Impact factor: 4.530

4.  The effects of dopamine agonists on prepulse inhibition in healthy men depend on baseline PPI values.

Authors:  Panos Bitsios; Stella G Giakoumaki; Sophia Frangou
Journal:  Psychopharmacology (Berl)       Date:  2005-09-29       Impact factor: 4.530

Review 5.  Epigenetics and biomarkers in the staging of neuropsychiatric disorders.

Authors:  Trevor Archer; Richard J Beninger; Tomas Palomo; Richard M Kostrzewa
Journal:  Neurotox Res       Date:  2010-03-17       Impact factor: 3.911

6.  Electrophysiology meets fMRI: neural correlates of the startle reflex assessed by simultaneous EMG-fMRI data acquisition.

Authors:  Irene Neuner; Tony Stöcker; Thilo Kellermann; Veronika Ermer; Hans Peter Wegener; Simon B Eickhoff; Frank Schneider; N Jon Shah
Journal:  Hum Brain Mapp       Date:  2010-11       Impact factor: 5.038

7.  Effect of apomorphine on cognitive performance and sensorimotor gating in humans.

Authors:  Arnt F A Schellekens; K P Grootens; C Neef; Kris L L Movig; J K Buitelaar; B Ellenbroek; R J Verkes
Journal:  Psychopharmacology (Berl)       Date:  2009-10-16       Impact factor: 4.530

8.  1-Methyl-1,2,3,4-tetrahydroisoquinoline antagonizes a rise in brain dopamine metabolism, glutamate release in frontal cortex and locomotor hyperactivity produced by MK-801 but not the disruptions of prepulse inhibition, and impairment of working memory in rat.

Authors:  Małgorzata Pietraszek; Jerzy Michaluk; Irena Romańska; Agnieszka Wasik; Krystyna Gołembiowska; Lucyna Antkiewicz-Michaluk
Journal:  Neurotox Res       Date:  2009-08-01       Impact factor: 3.911

9.  Effects of orbital prefrontal cortex dopamine depletion on inter-temporal choice: a quantitative analysis.

Authors:  S Kheramin; S Body; M-Y Ho; D N Velázquez-Martinez; C M Bradshaw; E Szabadi; J F W Deakin; I M Anderson
Journal:  Psychopharmacology (Berl)       Date:  2004-02-27       Impact factor: 4.530

10.  Sensorimotor gating of schizophrenia patients depends on Catechol O-methyltransferase Val158Met polymorphism.

Authors:  Boris B Quednow; Michael Wagner; Rainald Mössner; Wolfgang Maier; Kai-Uwe Kühn
Journal:  Schizophr Bull       Date:  2008-07-17       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.